Stifel Financial’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $37.2M | Sell |
290,957
-13,546
| -4% | -$1.69M | 0.03% | 433 |
|
|
2025
Q4 | $37.1M | Sell |
304,503
-19,165
| -6% | -$2.2M | 0.03% | 433 |
|
|
2025
Q3 | $32.4M | Buy |
323,668
+120,768
| +60% | +$10.9M | 0.03% | 474 |
|
|
2025
Q2 | $16.8M | Buy |
202,900
+8,025
| +4% | +$640K | 0.02% | 661 |
|
|
2025
Q1 | $15.8M | Sell |
194,875
-11,863
| -6% | -$1.06M | 0.02% | 659 |
|
|
2024
Q4 | $18.6M | Sell |
206,738
-81,371
| -28% | -$7.88M | 0.02% | 595 |
|
|
2024
Q3 | $28.5M | Buy |
288,109
+49,550
| +21% | +$4.87M | 0.03% | 454 |
|
|
2024
Q2 | $22.1M | Sell |
238,559
-12,090
| -5% | -$1.08M | 0.02% | 508 |
|
|
2024
Q1 | $23.8M | Buy |
250,649
+60,604
| +32% | +$5.62M | 0.03% | 483 |
|
|
2023
Q4 | $17M | Buy |
190,045
+6,901
| +4% | +$512K | 0.02% | 578 |
|
|
2023
Q3 | $13.4M | Sell |
183,144
-17,241
| -9% | -$1.38M | 0.02% | 618 |
|
|
2023
Q2 | $16.7M | Buy |
200,385
+8,075
| +4% | +$675K | 0.02% | 538 |
|
|
2023
Q1 | $14.7M | Sell |
192,310
-133,274
| -41% | -$11.1M | 0.02% | 554 |
|
|
2022
Q4 | $27M | Buy |
325,584
+38,274
| +13% | +$3.1M | 0.04% | 372 |
|
|
2022
Q3 | $22.8M | Buy |
287,310
+95,439
| +50% | +$8.05M | 0.04% | 395 |
|
|
2022
Q2 | $14.3M | Buy |
191,871
+582
| +0.3% | +$43.7K | 0.02% | 542 |
|
|
2022
Q1 | $17.2M | Buy |
191,289
+32,383
| +20% | +$2.99M | 0.02% | 549 |
|
|
2021
Q4 | $17.8M | Sell |
158,906
-6,750
| -4% | -$814K | 0.02% | 539 |
|
|
2021
Q3 | $20.8M | Buy |
165,656
+8,324
| +5% | +$1.07M | 0.03% | 463 |
|
|
2021
Q2 | $21.3M | Buy |
157,332
+22,594
| +17% | +$2.97M | 0.03% | 451 |
|
|
2021
Q1 | $18.3M | Buy |
134,738
+20,754
| +18% | +$3.11M | 0.03% | 455 |
|
|
2020
Q4 | $16M | Sell |
113,984
-18,912
| -14% | -$2.42M | 0.03% | 456 |
|
|
2020
Q3 | $14.8M | Buy |
132,896
+14,533
| +12% | +$1.63M | 0.03% | 426 |
|
|
2020
Q2 | $13.3M | Buy |
118,363
+37,969
| +47% | +$3.74M | 0.03% | 422 |
|
|
2020
Q1 | $6.23M | Buy |
80,394
+8,421
| +12% | +$746K | 0.02% | 596 |
|
|
2019
Q4 | $6.85M | Sell |
71,973
-14,983
| -17% | -$1.3M | 0.01% | 750 |
|
|
2019
Q3 | $6.62M | Sell |
86,956
-4,984
| -5% | -$414K | 0.02% | 711 |
|
|
2019
Q2 | $8.06M | Buy |
91,940
+6,786
| +8% | +$579K | 0.02% | 659 |
|
|
2019
Q1 | $7.71M | Sell |
85,154
-2,832
| -3% | -$241K | 0.02% | 634 |
|
|
2018
Q4 | $6.33M | Buy |
87,986
+2,560
| +3% | +$206K | 0.02% | 665 |
|
|
2018
Q3 | $8.21M | Buy |
85,426
+1,419
| +2% | +$138K | 0.02% | 628 |
|
|
2018
Q2 | $8.01M | Sell |
84,007
-2,216
| -3% | -$204K | 0.02% | 617 |
|
|
2018
Q1 | $7.55M | Buy |
86,223
+5,021
| +6% | +$458K | 0.02% | 639 |
|
|
2017
Q4 | $6.88M | Buy |
81,202
+633
| +0.8% | +$53K | 0.02% | 650 |
|
|
2017
Q3 | $6.97M | Sell |
80,569
-14,837
| -16% | -$1.19M | 0.02% | 622 |
|
|
2017
Q2 | $7.35M | Sell |
95,406
-50,198
| -34% | -$3.56M | 0.03% | 587 |
|
|
2017
Q1 | $10.1M | Buy |
145,604
+110,638
| +316% | +$7.43M | 0.04% | 458 |
|
|
2016
Q4 | $2.07M | Sell |
34,966
-3,713
| -10% | -$229K | 0.01% | 1019 |
|
|
2016
Q3 | $2.58M | Sell |
38,679
-2,272
| -6% | -$141K | 0.01% | 893 |
|
|
2016
Q2 | $2.21M | Buy |
40,951
+13,271
| +48% | +$727K | 0.01% | 949 |
|
|
2016
Q1 | $1.43M | Buy |
27,680
+3,987
| +17% | +$207K | 0.01% | 1068 |
|
|
2015
Q4 | $1.66M | Buy |
23,693
+1,377
| +6% | +$93.9K | 0.01% | 1047 |
|
|
2015
Q3 | $1.39M | Sell |
22,316
-526
| -2% | -$41.5K | 0.01% | 1081 |
|
|
2015
Q2 | $1.92M | Sell |
22,842
-3,276
| -13% | -$255K | 0.01% | 1023 |
|
|
2015
Q1 | $1.96M | Buy |
26,118
+13,776
| +112% | +$962K | 0.01% | 950 |
|
|
2014
Q4 | $767K | Buy |
12,342
+3,951
| +47% | +$225K | ﹤0.01% | 1407 |
|
|
2014
Q3 | $436K | Buy |
+8,391
| New | +$428K | ﹤0.01% | 1609 |
|
|
2014
Q2 | – | Sell |
-19,719
| Closed | -$937K | – | 2266 |
|
|
2014
Q1 | $937K | Buy |
+19,719
| New | +$1.01M | 0.01% | 1113 |
|
Other funds holding XBI
Stifel Financial's XBI Position: Q1 2026 in Review
Stifel Financial reduced its State Street SPDR S&P Biotech ETF (XBI) stake by 4.4% in Q1 2026, selling an estimated $1.69M and leaving 290,957 shares worth $37.2M. The position accounts for 0.03% of the portfolio, ranked #433.
Stifel Financial first reported a position in XBI in Q1 2014 and has held it in 48 quarters since. 813 funds tracked by Wall St. Rank hold XBI as of Q1 2026.
- Stifel Financial held 290,957 shares of State Street SPDR S&P Biotech ETF worth $37.2M as of Q1 2026.
- Stifel Financial sold 13,546 State Street SPDR S&P Biotech ETF shares in Q1 2026, an estimated $1.69M.
- State Street SPDR S&P Biotech ETF made up 0.03% of Stifel Financial's portfolio in Q1 2026, its #433 holding.
- Stifel Financial first reported a position in State Street SPDR S&P Biotech ETF in Q1 2014 and has held it in 48 quarters since.
- 813 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2026.
Based on Stifel Financial's 13F filing for Q1 2026, filed 12 May 2026.